Bio and generic demand driving increased internationalisation and renewed optimism amongst industry The Japanese pharma market is expected to grow quickly in 2019 following the release of a new report published ahead ofCPhI Japan 2019. The trade exhibition (18-20 March, 2019) will open its
MoreThere are many different factors and underlying health conditions that can affect energy levels from day to day, as well as
More[column]The U.S. Food and Drug Administration has approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after
More[column]The U.S. Food and Drug Administration has approved a new use of Gleevec (imatinib) to treat children newly diagnosed with
MoreThe U.S. Food and Drug Administration is alerting health care providers and patients of a voluntary nationwide recall of all
More[column]Novo Nordisk announced a unique partnership to form Team Novo Nordisk, a global sports team with more than 100 cyclists,
MoreSanofi (EURONEXT: SAN and NYSE: SNY) ranked third among twenty pharmaceutical companies on the 2012 Access to Medicine Index (ATM
More[column width=”360px” padding=”20px”]We are in the midst of third quarter earnings reports, and they show with stark detail what the
More[column width=”360px” padding=”20px”]The supercharged race to get new treatments into the lucrative market for treating rheumatoid arthritis (RA) appeared to
More